A study reported that Cx43 significantly increased glioblastoma cell sensitivity to paclitaxel and doxorubicin [161]; therefore, a high expression of Cx43 may be exploited with the delivery of the targeted drug to cancer cells via enhanced drug permeability. This evidence concerns the gene GJA1 and glioblastoma.